Tag: Altace

Yes, ramipril can cause nausea, although it is a less common side effect compared to the persistent cough or dizziness associated with this medication. Clinical trial data indicates that approximately 2% of patients taking ramipril reported experiencing nausea. Understanding how to manage this symptom is essential for those who experience it.

Approximately 1–10% of people taking ramipril experience headaches, particularly when first starting the medication. Understanding why this occurs and how to manage it can help you navigate this common side effect, especially when your body is adjusting to the new medication.

Yes, a dry cough is a well-documented and common side effect of ramipril, affecting a significant portion of users. This persistent, irritating cough is a hallmark side effect of the entire class of medications known as ACE inhibitors.

According to clinical studies, up to 20% of people who take ramipril develop a dry, tickling cough, making it the most common side effect of ramipril. This persistent cough is a well-documented class effect of angiotensin-converting enzyme (ACE) inhibitors, the drug class to which ramipril belongs. While generally not dangerous, it can be quite bothersome and may not resolve on its own, often requiring a change in medication.

While typically a mild and transient side effect, studies indicate that diarrhea is a reported adverse event associated with the use of the ACE inhibitor ramipril. Occurring in a small percentage of patients, it's a known, though not extremely common, gastrointestinal issue for those taking this medication.

High blood pressure affects millions of adults, and controlling it is crucial for preventing serious health problems. Ramipril, an angiotensin-converting enzyme (ACE) inhibitor, is a widely prescribed medication used to treat hypertension and several other cardiovascular conditions. This guide explains the key therapeutic uses and mechanisms of this important drug.

In 2010, Pfizer announced its acquisition of King Pharmaceuticals for $3.6 billion, a deal which included King's subsidiary, Monarch Pharmaceuticals [1.4.9, 1.5.3]. When asking 'What is a monarch drug?', the answer usually points to a legacy product from this company, though the term also has an entirely different, classical meaning in pharmacology.